FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Baumel Alan
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/20/2021 

3. Issuer Name and Ticker or Trading Symbol

HeartBeam, Inc. [BEAT]
(Last)        (First)        (Middle)

2118 WALSH AVE, SUITE 210
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Operating Officer /
(Street)

SANTA CLARA, CA 95050      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock (right to buy)  (1)11/12/2031 Common Stock 82000.0 $4.25 D  

Explanation of Responses:
(1) The option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the vesting commencement date October 6, 2021 and one thirty-sixth (1/36th) of the shares subject to the option shall vest each calendar month thereafter on the same day of the month as the vesting commencement date, such that 100% of the shares subject to the option will be fully vested and exercisable on September 6, 2025.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Baumel Alan
2118 WALSH AVE, SUITE 210
SANTA CLARA, CA 95050


Chief Operating Officer

Signatures
/s/ Alan Baumel12/23/2021
**Signature of Reporting PersonDate

HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more HeartBeam Charts.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more HeartBeam Charts.